1. Home
  2. PMAX vs COEP Comparison

PMAX vs COEP Comparison

Compare PMAX & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMAX
  • COEP
  • Stock Information
  • Founded
  • PMAX 2019
  • COEP 2017
  • Country
  • PMAX Hong Kong
  • COEP United States
  • Employees
  • PMAX N/A
  • COEP N/A
  • Industry
  • PMAX
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • PMAX
  • COEP Health Care
  • Exchange
  • PMAX Nasdaq
  • COEP Nasdaq
  • Market Cap
  • PMAX 32.0M
  • COEP 32.4M
  • IPO Year
  • PMAX 2024
  • COEP N/A
  • Fundamental
  • Price
  • PMAX $0.51
  • COEP $12.34
  • Analyst Decision
  • PMAX
  • COEP
  • Analyst Count
  • PMAX 0
  • COEP 0
  • Target Price
  • PMAX N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • PMAX 4.4M
  • COEP 114.7K
  • Earning Date
  • PMAX 02-21-2025
  • COEP 03-25-2025
  • Dividend Yield
  • PMAX N/A
  • COEP N/A
  • EPS Growth
  • PMAX N/A
  • COEP N/A
  • EPS
  • PMAX 0.04
  • COEP N/A
  • Revenue
  • PMAX $5,970,263.00
  • COEP N/A
  • Revenue This Year
  • PMAX N/A
  • COEP N/A
  • Revenue Next Year
  • PMAX N/A
  • COEP N/A
  • P/E Ratio
  • PMAX $9.74
  • COEP N/A
  • Revenue Growth
  • PMAX 30.05
  • COEP N/A
  • 52 Week Low
  • PMAX $0.34
  • COEP $2.31
  • 52 Week High
  • PMAX $4.70
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • PMAX N/A
  • COEP 62.70
  • Support Level
  • PMAX N/A
  • COEP $8.65
  • Resistance Level
  • PMAX N/A
  • COEP $13.70
  • Average True Range (ATR)
  • PMAX 0.00
  • COEP 1.76
  • MACD
  • PMAX 0.00
  • COEP -0.18
  • Stochastic Oscillator
  • PMAX 0.00
  • COEP 72.97

About PMAX Powell Max Limited Class A Ordinary Shares

Powell Max Ltd is an financial communications services provider. Its financial communications services cover a full range of financial printing, corporate reporting, communications and language support services from inception to completion, including typesetting, proofreading, translation, design, printing, electronic reporting, newspaper placement and distribution. It operates in a single business segment which is the provision of corporate financial communications and financial printing services. Key revenue is derived from Hong Kong.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: